These findings suggest that cystatin C could serve as an early biomarker for AKI, offering earlier detection and identification of at-risk patients before notable renal dysfunction occurs, compared to serum creatinine (Table 4). The increase in cystatin C levels may indicate early renal injury or impaired glomerular filtration. This evidence concerns the gene CST3 and acute kidney injury.